Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

Delayed Data
As of May 26
 -2.87 / -5.21%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 74.50, with a high estimate of 86.00 and a low estimate of 36.00. The median estimate represents a +42.80% increase from the last price of 52.17.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.09%
Growthannually 45.45%


Growthquarterly 96.67%
Growthannually 90,380.99%
Key to the earnings and sales forecast charts.